Unmet Needs in the Management of Gastroesophageal Reflux Disease

Size: px

Start display at page:

Download "Unmet Needs in the Management of Gastroesophageal Reflux Disease"

Vivien Preston
5 years ago
Views:

1 Unmet Needs in the Management of Gastroesophageal Reflux Disease Ronnie Fass MD Professor of Medicine Case Western Reserve University Chairman, Division of Gastroenterology and Hepatology Director, Esophageal and Swallowing Center MetroHealth Medical Center Cleveland, Ohio USA

2 Patients Report Attributes Extremely Important when Selecting Stomach Relief Medication Fast-acting relief (79%) Long lasting (67%) No side effects (60%) Effectively blocks symptoms (55%) Economical price (48%) One dose prevents breakthrough symptoms (48%) One dose lasts hours (42%) Recommended by doctor (39%) Comes in a form I want (34%) Don t need prescription (32%) N = 1004 Gallup Organization. The 2000 Gallup Study of Consumers' Use of Stomach Relief Products.

3 What are the Areas of Unmet Need in GERD? Advance grading of erosive esophagitis (15-30% 20%) Dickman R et al J Neurogastroenterol Motil 2015 (in press)

4 Erosive Esophagitis Healing by Baseline LA Grade Omeprazole Esomeprazole Patients Healed (% * * * * 0 Grade A Grade B Grade C Grade D N=813 N=972 N=497 N=140 P<0.01 Cochran-Mantel-Haenszel. Richter et al. Am J Gastroenterol 2002 Week 8

5 Patients With Heartburn Symptoms, % Symptoms Persist in Some Erosive Esophagitis Patients Despite PPI Treatment Patients With Incomplete Symptom Relief After 8 Wks of PPI Therapy Richter N= Kahrilas N= Castell N= Fennerty N= Labenz N= Katz et al. Aliment Pharmacol Ther. 2006;23(suppl 2):9-22.

$Endoscopically Confirmed Healing Rates of Refractory Reflux Esophagitis$

6 Endoscopically Confirmed Healing Rates of Refractory Reflux Esophagitis after 8 weeks of Treatment Kinoshita et al. Am J Gastroenterol 2012;107:

7 Kinoshita et al. Am J Gastroenterol 2012;107:

8 What are the Areas of Unmet Need in GERD? Advance grading of erosive esophagitis (15-30% 20%) Nonerosive reflux disease (70% 40%) Dickman R. et al J Neurogastroenterol Motil 2015 (in press)

9 Symptom Response Rate to Standard Dose PPI Therapy in Patients with NERD versus Patients with Erosive Esophagitis Standard-dose PPI Therapy Placebo Pooled symptomatic response rate at 4 weeks (%) NERD (N=1854) Erosive esophagitis (N=705) *P< compared with patients with NERD * Dean et al. Clin Gastroenterol Hepatol 204;2:

10 Comparison of Response to Proton Pump Inhibitor Treatment Between NERD and Erosive Esophagitis Patients NERD Erosive esophagitis Lag time to sustained symptomatic relief 6 days 4 5 days Symptomatic response to standard versus half dose No difference Increase Fass R, J Clin Gastroenterol 2007; 41:131-=137

11 Treatment Comparison between Placebo and PPI Once Daily in NERD Patients (Pooled Difference in Proportion with Heartburn Resolution by Time) Dean et al. Clin Gastroenterol Hepatol 2004;2:

12 Proportion of NERD Patients Responding to Treatment at 4 Weeks Omeprazole 20mg Omeprazole 10mg Placebo 61 % patients Complete absence of heartburn Resolution of heartburn Lind et al. Scand J Gastroenterol 1997 N = 509

13 Exclude Functional Reflux Hypersensitivity and Functional Heartburn Patient with heartburn Endoscopy Normal endoscopy ph testing 50% abnormal normal 50% Symptom index 37% Positive Negative 63% Responsive PPI treatment Not responsive Functional reflux hypersensitivity Functional heartburn

14 Esophageal Hypersensitivity Very Common in NERD Trimble KC et al. Gut 1995;37:7-12. Maradey Romero et al.cgh Esophageal Hypersensitivity The perception of nonpainful esophageal stimuli as being painful, and painful esophageal stimuli as more painful 86% of NERD

15 Pain Modulators: An Additional Treatment For NERD? Antidepressants TCA s, SSRIs,SNRIs and Trazodone Adenosin agonists Serotnin agonists Antiepileptics (theophylline) (tegaserod) (Pregabalin) Peripheral neuropathy analgesics (Gabapentin) Alternative and complimentary medicine Dickman R, Maradey-Romero C, Fass R. Neurogastroenterol and Motil 2014;26:

16 What are the Areas of Unmet Need in GERD? Advance grading of erosive esophagitis (15-30% 20%) Nonerosive reflux disease (70% 40%) Postprandial heartburn (OTC market) Dickman R et al. J Neurogastroenterol Motil 2015 (in press)

17 ph Postprandial Heartburn A Therapeutic Challenge meal heartburn 0 16:00 17:00 18:00 19:00 Time (PM) Orr WC. Am J Med. 2003;115(Suppl 3A):S109-S113.

18 Potassium Competitive Acid Blockers (P-CAB) - Mean steady-state intragastric ph profiles on Day 7 With Vonoprazan (TAK-438) Jenkins R et al. Gut 2012 (Suppl.)

19 What are the Areas of Unmet Need in GERD? Advance grading of erosive esophagitis (15-30% 20%) Nonerosive reflux disease (70% 40%) Postprandial heartburn (OTC market) Nighttime heartburn (50% 38%) Dickman R et al. J Neurogastroenterol Motil 2015 (in press)

20 Breakthrough Nighttime Symptoms on PPI Once Daily During sleep 28 Breakthrough symptoms, 38% At night 65 No breakthrough symptoms, 62% Mid day 45 N=1064 In the morning 16 American Gastroenterology Association. GERD Patient Study: Patients and Their Medications. Harris Interactive Inc; 2008.

Percentage of Symptomatic GERD Patients with Relief of Nighttime Heartburn (Esomeprazole 20 mg for 4 weeks) 60 50 Patients with relief of nighttime

21 Percentage of Symptomatic GERD Patients with Relief of Nighttime Heartburn (Esomeprazole 20 mg for 4 weeks) Patients with relief of nighttime heartburn % * Esomeprazole 20 mg (N=137) Johnson D et al. Aliment Pharmacol Ther 2010;32: Placebo (N=125) *P< vs placebo

22 Therapeutic options for Nighttime GERD Avoid eating at least 3 hours prior bedtime Elevate the head of the bed Avoid the R decubitus position in bed Turn off lights when enter bed and minimize disturbances to a normal sleep Treat with a PPI and if symptoms are primarily during nighttime - give before dinner Split PPI dose (am and pm before a meal) Add H2RA, carafate, gaviscon etc. before bedtime Consider non-medical treatment Fujiwara Y et al. J Gastroenterol 2012:47:760-9.

23 The Effect of Dexlansoprazole MR on Nighttime GERD Symptoms and Sleep Disturbances Relief= 6 of 7nights w/ no HB, allows 1 night w/ mild HB; 6 of 7 nights w/ no GERDrelated sleep disturbance

24 Should We Consider Combined Treatment For GERD? Decrease Sleep Decrease Alter Esophageal physiology Increase Increase GERD Increase Schey et al. Gastroenterology 2007; 133:

Ramelteon Consider for Nighttime GERD Non-Scheduled hypnotic A selective MT1 and MT2 agonist Pharmacological structure close to omeprazole (

25 Ramelteon Consider for Nighttime GERD Non-Scheduled hypnotic A selective MT1 and MT2 agonist Pharmacological structure close to omeprazole ( crude omeprazole ) Reduce Acid secretion and improve sleep Lokesh Jha et al JCG 2015 (in press) Nighttime heartburn Daytime heartburn *p<0.05

26 What are the Areas of Unmet Need in GERD? Advance grading of erosive esophagitis (15-30% 20%) Nonerosive reflux disease (70% 40%) Postprandial heartburn (OTC market) Nighttime heartburn (50% 38%) On-demand / intermittent Dickman R et al. J Neurogastroenterol Motil 2015 (in press)

27 GERD A Symptom Driven Disease I have heartburn I will take my medication Fass et al. Aliment Pharmacol Ther 2005;22(2):79-94.

28 On Demand Usage In Clinical Practice Of those taking lansoprazole or omeprazole over 30 days, how many days were they actually taken? Percent (%)) % 11% 5% 6% 8% 55% days 4-6 days 7-9 days days days 30 days 2000 Gallup Study of Consumer Use of Heartburn Products, May 2000.

29 On-Demand / Intermittent Treatment for GERD Intermittent Therapy Physician driven Administration of short, predetermined courses of therapy when symptoms recur (1 or 2 weeks duration). On-demand Therapy Patient driven Consumption of medical therapy when and during periods that patients desire.

On-Demand Rabeprazole Therapy in Nonerosive Reflux Disease 50 40 5 4 4.6 Rab 10 mg (n = 279) 30 20 20 3 2 2.

30 On-Demand Rabeprazole Therapy in Nonerosive Reflux Disease Rab 10 mg (n = 279) Placebo (n = 139) Patient Discontinuation* (%) 0 Mean Weekly Antacid Consumption (n) *Due to inadequate heartburn control. P < ; P <0.0011; all comparisons vs placebo. Bytzer P, et al. Aliment Pharmacol Ther. 2004;20:

31 Cost-effectiveness of Different Therapeutic Strategies Decision analysis i. Lifestyle modifications plus antacids ii. H2RA to endoscopy iii. Step-up iv. Step-down v. PPI on demand vi. PPI maintenance PPI on-demand more effective and less costly Gerson L et al. Am J Gastroenterol. 2000;95:395.

32 What are the Areas of Unmet Needs in GERD? Advance grading of erosive esophagitis (15-30% 20%) Nonerosive reflux disease (70% 40%) Postprandial heartburn (OTC market) Nighttime heartburn (50% 38%) Maintenance treatment (30%) Dickman R et al. J Neurogastroenterol Motil 2015 (in press)

33 Maintenance Treatment Relapse Rates of Esophagitis Are High The majority will relapse without maintenance PPI therapy 15%-23% of LA grade A/B patients relapse within 6 months on maintenance PPI therapy 24%-41% of LA grade C/D patients relapse within 6 months on maintenance PPI therapy Lauritsen et al. Aliment Pharmacol Ther. 2003;17:

34 What are the Areas of Unmet Needs in GERD? Advance grading of erosive esophagitis (15-30% 20%) Nonerosive reflux disease (70% 40%) Postprandial heartburn (OTC market) Nighttime heartburn (50% 38%) Maintenance treatment (30%) On-demand / intermittent (80-90%) Refractory GERD (30-40%) Atypical manifestations of GERD (noncardiac chest pain) Dickman R et al. J Neurogastroenterol Motil 2015 (in press)

35 What are the Areas of Unmet Needs in GERD? Advance grading of erosive esophagitis (15-30% 20%) Nonerosive reflux disease (70% 40%) Postprandial heartburn (OTC market) Nighttime heartburn (50% 38%) Maintenance treatment (30%) On-demand / intermittent (80-90%) Refractory GERD (30-40%) Atypical manifestations of GERD (noncardiac chest pain) Extraesophageal manifestations of GERD Dickman R et al. J Neurogastroenterol Motil 2015 (in press)

36 Comparative Trial Between Esomeprazole 40mg Twice Daily Versus Placebo In Patients With Laryngeal Manifestations Of GERD 4 months

37 Laryngeal Manifestations Of GERD Vs.

39 Functional Laryngeal/Pharyngeal Disorders Embrace Them! Chronic Cough Throat clearing Throat Burning Throat Pain The burning mouth syndrome Dickman R et al. Neurogastroenterol Motil 2014;26:603-10

40 What are the Areas of Unmet Needs in GERD? Advance grading of erosive esophagitis (15-30% 20%) Nonerosive reflux disease (70% 40%) Postprandial heartburn (OTC market) Nighttime heartburn (50% 38%) Maintenance treatment (30%) On-demand / intermittent (80-90%) Refractory GERD (30-40%) Atypical manifestations of GERD (noncardiac chest pain) Extraesophageal manifestations of GERD PPIs Dependence on food for efficacy Dickman R et al. J Neurogastroenterol Motil 2015 (in press)

Mean ph Level DEXILANT Can Be Taken Without Regard to Food Mean Intragastric ph Over Time on Day 3 While on Dexlansoprazole 90 mg Daily Fasting 30 min after

41 Mean ph Level DEXILANT Can Be Taken Without Regard to Food Mean Intragastric ph Over Time on Day 3 While on Dexlansoprazole 90 mg Daily Fasting 30 min after high-fat breakfast 5 min before high-fat breakfast 30 min before high-fat breakfast Lee RD et al. Aliment Pharmacol Ther. 2009;29(8): Hours From Dosing

42 Potassium Channel Blockers Bind reversibly and K competatively to the ATPase ( plasma level cell drug level) Able to inhibit the proton pump without acid activation ( not meal dependent) Weak base that accumulates in the parietal cell canaliculus. Potency is increased as a function of the pk a Rapid onset of effect complete acid blockade within 30 min. of administration Good oral bio-availability Maradey Romero & Fass Curr Gastroenterol Rep 2014;16:390

43 What are the Areas of Unmet Needs in GERD? Advance grading of erosive esophagitis (15-30% 20%) Nonerosive reflux disease (70% 40%) Postprandial heartburn (OTC market) Nighttime heartburn (50% 38%) Maintenance treatment (30%) On-demand / intermittent (80-90%) Refractory GERD (30-40%) Atypical manifestations of GERD (noncardiac chest pain) Extraesophageal manifestations of GERD PPIs Dependence on food for efficacy Alternative approaches to chronic PPI treatment Dickman R et al. J Neurogastroenterol Motil 2015 (in press)

44 Alternative Therapeutic Approaches Medical to Chronic PPI Treatment H2 blockers Antacids/ Gaviscon / sucralfate Prokinetics Baclofen Pain modulators Non-Medical Lifestyle modifications Endoscopic treatment Anti-reflux surgery Linx Psychological interventions Acupuncture Fass R. Clin Gastroenterol Hepatol 2012;10:

45 New Area Of Unmet Need In GERD Bariatric Surgery

47 Esophageal Stricture Post Band Ligation

48 Severe Erosive Esophagitis After Sleeve Gastrectomy

50 The End

GERD: 2014 Dilemmas and Solutions. Ronnie Fass MD, FACP Professor of Medicine Case Western Reserve University

GERD: 2014 Dilemmas and Solutions Ronnie Fass MD, FACP Professor of Medicine Case Western Reserve University How to Maximize Your PPI Treatment? Improve compliance and adherance Fass R. Am J Gastroenterol.